한국어
Quantus

Aehr Test Systems

AEHR · Nasdaq
$86.26+13.10%
2026-09-04 close

Aehr Test Systems last closed at $86.26 (+13.10%) on 2026-09-04. Listed on Nasdaq; price, financials and dividends update daily after market close.

Loading chart…
Close
Market Leader RS 98 · top 2%

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
277 picks
Next-day win rate
44.2%
Avg next-day
-0.28%
vs market
-0.51%p

Every new-high-plus-volume pick we actually published (US market) — not this stock alone.

Signal history

DateSignal+20 trading days

A record, not a prediction.

How this is calculated

"·" means fewer than 20 trading days have passed since the event. Cup-and-handle entries are days our board actually showed the badge (archive grows daily since 2026-05-12); others are recomputed from price data.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

A-
Overall: 반도체 25/89 · top 27%
Factor composite · relative position in sector

PER — · PBR 21.07 — own-history percentile 66/100 · 3/100

Open self-history band
PER66/100
PBR3/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Financial safety

Reference indicatorAs of 2025
Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 7.50
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
7.50
Beneish M-Score
-1.77

Statistical manipulation-risk signal

Sloan accrual
2.35%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Why has this company moved this way?

Auditable observations with the original numeric evidence.

매출 하락 → 마진 압박 → 현금 악화

Critical

매출이 -10.9% 감소하며 영업이익률이 15.2%에서 -9.6%로 하락했다. 영업현금흐름도 동반 감소하여 수익-현금 순환이 약화되고 있다.

Evidence

매출 YoY -10.9% (2024→2025)영업이익률 15.2%→-9.6%영업CF 2→-7

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

0/9Weak

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score0/9

Profitability

  • Positive ROANot passed
  • Positive OCFNot passed
  • Improving ΔROANot passed
  • Accruals (OCF > net income)Not passed

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioNot passed
  • No new sharesNot passed

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Revenue qualityDanger

매출 흑자인데 영업CF 적자 (OCF/매출 -13%). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Cash conversion cycleWarning

현금전환주기(CCC) 3기 연속 확대 — 운전자본 경색·현금 회수 지연 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Margin trendWarning

영업이익률 악화 (15.2% → -9.6%, -24.8%p). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Margin trendWarning

영업외손익 급변 (영업이익 대비 375% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Industry structure

USAs of 2026-09-05

반도체

This stock is in 반도체: revenue rank 69 of 87, share 0%.

69 / 870%revenue share

Who dominates this industry?

  1. 1NVIDIA22.9%
  2. 2Broadcom11.2%
  3. 3Intel Corporation9.3%
  4. 4QUALCOMM7.8%
  5. 5Micron Technology6.6%
  6. 6Aehr Test Systems0%

Concentration

DistributedCR3 43.5%
HHI 95387 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

Winner-take-all deepeningConsistent

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p
34.34
Direction
확대
Level
넓음
Years
8

Value lens

P90/P10
17.2
Median P/B
3.97
Level
넓음
n
82

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
-9.6%
Interest coverage
-3.2x
Return on equity (ROE)
-3.2%

Operating margin −5pp

Operating loss
Interest coverageBase -3.2x adverse case -4.9x
Return on equity (ROE)Base -3.2% adverse case -8.5%

Revenue −15%

Interest coverage risk
Interest coverageBase -3.2x adverse case -2.7x
Return on equity (ROE)Base -3.2% adverse case -5.4%

Interest rate +2pp

Interest coverage risk
Interest coverageBase -3.2x adverse case -2.5x
Return on equity (ROE)Base -3.2% adverse case -6.5%

Interest coverage limit

Already below the limit by 12.6pp

Interest coverage limit at an operating margin of 3%

Interest expense coverage threshold

Connections

AI-extracted related companies · for reference

🔗 See in the full market map →

Recent filings

Filings for overseas stocks are on the way. For now we cover Korean stocks only.

About Aehr Test Systems
What technical signals does Aehr Test Systems (AEHR) have?
Aehr Test Systems current technical signals: no active technical signal.
Is Aehr Test Systems a cup-and-handle pattern?
No. Aehr Test Systems has no valid cup-and-handle signal right now.
What are Aehr Test Systems's financials and valuation?
Aehr Test Systems's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy